SMTL ID : 6gqt.6 (5 other biounits)

KRAS-169 Q61H GPPNHP + PPIN-2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)

GNP.1: 21 residues within 4Å: Chain A: G.15, G.16, V.17, G.18, K.19, S.20, A.21, F.31, V.32, D.33, E.34, A.62, G.63, N.119, K.120, D.122, L.123, S.148, A.149, K.150 Ligands: MG.2 19 PLIP interactions: 19 interactions with chain A Hydrogen bonds: A:G.16, A:V.17, A:G.18, A:K.19, A:K.19, A:K.19, A:S.20, A:A.21, A:V.32, A:G.63, A:N.119, A:K.120, A:S.148, A:A.149, A:K.150 Water bridges: A:K.120, A:K.120 Salt bridges: A:D.122 pi-Stacking: A:F.31

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: S.20, D.60 Ligands: GNP.1 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:S.20, H2O.1

1 x F8N: ~{N}-(3-imidazol-1-ylpropyl)-4-[[3-(3-methoxyphenyl)phenyl]methyl]oxane-4-carboxamide(Non-covalent)

F8N.3: 12 residues within 4Å: Chain A: K.8, L.9, V.10, S.42, Y.43, R.44, D.57, I.58, L.59, Y.74, T.77, G.78 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:K.8, A:V.10, A:D.57, A:L.59 Hydrogen bonds: A:S.42, A:T.77

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cruz-Migoni, A. et al., Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proc. Natl. Acad. Sci. U.S.A. (2019)

Release Date

2019-02-06

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

GTPase KRas

Related Entries With Identical Sequence